Amphastar Pharmaceuticals, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2012 | $204.3M | $25.4M | $18.1M |
| FY2013 | $229.7M | $17.5M | $11.9M |
| FY2014 | $210.5M | $-18.0M | $-10.7M |
| FY2015 | $251.5M | $-6.9M | $-2.8M |
| FY2016 | $255.2M | $15.4M | $9.8M |
| FY2017 | $240.2M | $-1.3M | $3.6M |
| FY2018 | $294.7M | $-8.6M | $-5.7M |
| FY2019 | $322.4M | $-39.0K | $48.9M |
| FY2020 | $349.8M | $11.0M | $1.4M |
| FY2021 | $437.8M | $69.9M | $62.1M |
| FY2022 | $499.0M | $107.5M | $91.4M |
| FY2023 | $644.4M | $197.0M | $137.5M |
| FY2024 | $732.0M | $205.4M | $159.5M |
| FY2025 | $719.9M | $140.4M | $98.1M |